"During fiscal 2008, we positioned Pharsight for accelerated long term growth," added Mr. O'Connor. "We strengthened our balance sheet, continued to make investments in our product development and infrastructure and expanded our consulting service offerings. Based on the progress made during the past year, we are able to forecast a higher revenue growth rate for fiscal 2009. In addition, we believe that we will generate increased operating margins and enhanced profitability for the full fiscal year."
Pharsight's recent highlights in its software and consulting services
-- Achieved 14% revenue growth in fiscal 2008 compared with fiscal 2007.
-- Added 22nd PKS customer.
-- Achieved sixth WinNonlin AutoPilot customer within first nine months
since product launch.
-- Added two new DMX customers to bring total to eleven.
Strategic Consulting Services (SCS)
-- Continued to diversify revenue base with top five customers
representing 59% of revenue compared with 82% in the same period last
-- Engaged four new customers.
-- Continued to make featured presentations at key industry meetings
including the American Society for Clinical Pharmacology and
Therapeutics (ASCPT) and the American Conference on Pharmacometrics
Reporting and Analysis Services (RAS)
-- Engaged six new customers.
-- Integrated PKS with WinNonlin and AutoPilot in a validated solution for
-- Expanded the RAS team in response to global demand for the group's
services; team now totals 12 professiona
|SOURCE Pharsight Corporation|
Copyright©2008 PR Newswire.
All rights reserved